DoW Peer Reviewed Medical, Lifestyle and Applied Health Research Award

Closed Posted

Opportunity number
HT942526PRMRPLAHRA
Agency
Applications due
Award size
Not on record

Opportunity facts

Assistance listings
Funding instrument
Cooperative Agreement, Grant
Category
  • Science and Technology and other Research and Development
Eligible applicants
  • Unrestricted
Points of contact

Opportunity details come from Grants.gov. Updated .

About this opportunity

The Defense Health Agency, through the Department of the Army Medical Command, is seeking clinical research and clinical trial applications that utilize interdisciplinary scientific approaches including occupational science, psychology, biostatistics, epidemiology, implementation science, and population health to address congressionally directed health priorities. Applicants must address one designated FY26 PRMRP topic area and one FY26 PRMRP strategic goal across nine portfolios spanning autoimmune disorders, cardiovascular health, infectious diseases, neuroscience and mental health, orthopaedic medicine, and other medical domains. A distinctive requirement mandates the participation of a patient advocate—an individual living with or a family member or caretaker of someone with the targeted disease or condition. Applications undergo a rigorous two-tier review process evaluating technical merit, research strategy and feasibility, transition planning, and personnel qualifications, with animal research and clinical trials involving FDA-regulated pharmacological interventions explicitly prohibited. The Letter of Intent deadline is July 23, 2026, at 5:00 p.m. Eastern Time, with full applications due August 6, 2026, at 11:59 p.m. Eastern Time; extramural organizations must submit through Grants.gov while intramural Department of War organizations submit through eBRAP.

The Defense Health Agency anticipates awarding approximately $16.8 million across four Lifestyle and Applied Health Research Award applications, with individual award caps of $4.2 million per project and a maximum performance period of four years. FY26 funds are available for use through September 30, 2032, with awards expected to be made no later than September 30, 2027. Research will be conducted at eligible extramural and intramural organizations, including academic medical centers and research institutions across the United States, with select international collaborations permitted.

Synopsis

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Lifestyle and Applied Health Research Award supports clinical research and/or clinical trials using a combination of scientific disciplines including occupational science, psychology, psychometrics, biostatistics and epidemiology, surveillance, implementation science, and population health. Applications must address and provide a solution to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals.


Distinctive Features: This funding opportunity requires patient advocate participation. The patient advocate will be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas. Animal research is not allowed.


Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $16.8M to fund approximately four Lifestyle and Applied Health Research Award applications with total cost caps of $4.2M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

Files

File Type Posted
HT942526PRMRPLAHRA_GG.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity